UniProt A0A0B4WYC6
NS3 protease (A0A0B4WYC6)
NS3 protease (UniProt A0A0B4WYC6), EC 3.4.21.-, 3.4.21.98: 72 experimental structures on GenesisL1, 28 ligands bound, 52 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- A0A0B4WYC6
- Protein
- NS3 protease
- EC
- 3.4.21.-, 3.4.21.98
- Experimental structures
- 72
- Predicted models
- 0
- Ligands
- 28
- Pockets
- 52 · 1 record with a druggable one
Structures
72 records of A0A0B4WYC6 in the MolNFT archive: 72 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6CVW | Crystal structure of HCV NS3/4A WT protease in complex with AJ-52 (MK-5172 linear analogue) | x-ray diffraction | A | ZN, SO4, FH1 | 2 (best 0.42) |
| 6CVW | Crystal structure of HCV NS3/4A wt protease in complex with aj-52 (mk- 5172 linear analogue) | x-ray diffraction | A | ZN, SO4, FH1 | — |
| 6CVX | Crystal structure of HCV NS3/4A WT protease in complex with AJ-50 (MK-5172 linear analogue) | x-ray diffraction | A | FH4, SO4, ZN | — |
| 6CVX | Crystal structure of HCV NS3/4A wt protease in complex with aj-50 (mk- 5172 linear analogue) | x-ray diffraction | A | FH4, SO4, ZN | — |
| 6CVY | Crystal structure of HCV NS3/4A WT protease in complex with AJ-21 (MK-5172 linear analogue) | x-ray diffraction | A | ZN, SO4, FHD | 1 (best 0.31) |
| 6CVY | Crystal structure of HCV NS3/4A wt protease in complex with aj-21 (mk- 5172 linear analogue) | x-ray diffraction | A | ZN, SO4, FHD | — |
| 6DIQ | Crystal structure of HCV NS3/4A protease in complex with P4-P5-1 (WK-23) | x-ray diffraction | A | GK7, SO4, ZN | 2 (best 0.38) |
| 6DIQ | Crystal structure of HCV NS3/4A protease in complex with P4-P5-1 (wk- 23) | x-ray diffraction | A | GK7, SO4, ZN | — |
| 6DIR | Crystal structure of HCV NS3/4A protease in complex with P4-P5-2 (AJ-67) | x-ray diffraction | A | GKA, SO4, ZN | 1 (best 0.31) |
| 6DIR | Crystal structure of HCV NS3/4A protease in complex with P4-P5-2 (aj- 67) | x-ray diffraction | A | GKA, SO4, ZN | — |
| 6DIS | Crystal structure of HCV NS3/4A protease in complex with P4-1 (AJ-71) | x-ray diffraction | A | GKG, SO4, ZN | 2 (best 0.31) |
| 6DIS | Crystal structure of HCV NS3/4A protease in complex with P4-1 (aj-71) | x-ray diffraction | A | GKG, SO4, ZN | — |
| 6DIT | Crystal structure of HCV NS3/4A protease in complex with P4-2 (JZ01-19) | x-ray diffraction | A | GKJ, ZN | 2 (best 0.43) |
| 6DIT | Crystal structure of HCV NS3/4A protease in complex with P4-2 (JZ01- 19) | x-ray diffraction | A | GKJ, ZN | — |
| 6DIU | Crystal structure of HCV NS3/4A protease in complex with P4-3(AJ-74) | x-ray diffraction | A | ZN, SO4, GKM | 1 (best 0.30) |
| 6DIU | Crystal structure of HCV NS3/4A protease in complex with P4-3(AJ-74) | x-ray diffraction | A | ZN, SO4, GKM | — |
| 6DIV | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-2 (AJ-67) | x-ray diffraction | A | GKA, ZN, SO4 | 1 (best 0.31) |
| 6DIV | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-2 (aj-67) | x-ray diffraction | A | GKA, ZN, SO4 | — |
| 6DIW | Crystal structure of HCV NS3/4A D168A protease in complex with P4-1 (AJ-71) | x-ray diffraction | A | GKG, SO4, ZN | 2 (best 0.39) |
| 6DIW | Crystal structure of HCV NS3/4A D168A protease in complex with P4-1 (aj-71) | x-ray diffraction | A | GKG, SO4, ZN | — |
| 6N4N | Crystal structure of the designed protein DNCR2/danoprevir/NS3a complex | x-ray diffraction | A, B | ZN, TSV, SO4 | 9 (best 0.89) |
| 6N4N | Crystal structure of the designed protein DNCR2/DANOPREVIR/NS3A complex | x-ray diffraction | A, B | ZN, TSV, SO4 | — |
| 6PIU | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-6 (NR03-68) | x-ray diffraction | A | ZN, OL7 | 2 (best 0.41) |
| 6PIU | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-6 (NR03-68) | x-ray diffraction | A | ZN, OL7 | — |
| 6PIV | Crystal structure of HCV NS3/4A D168A protease in complex with P4-7 (NR03-77) | x-ray diffraction | A | ZN, OLJ, SO4 | 1 (best 0.32) |
| 6PIV | Crystal structure of HCV NS3/4A D168A protease in complex with P4-7 (NR03-77) | x-ray diffraction | A | ZN, OLJ, SO4 | — |
| 6PIW | Crystal structure of HCV NS3/4A D168A protease in complex with P4-6 (NR03-67) | x-ray diffraction | A | ZN, OLV | — |
| 6PIW | Crystal structure of HCV NS3/4A D168A protease in complex with P4-6 (NR03-67) | x-ray diffraction | A | ZN, OLV | — |
| 6PIX | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-5 (WK-25) | x-ray diffraction | A | ZN, OLY, SO4 | 1 (best 0.33) |
| 6PIX | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-5 (wk-25) | x-ray diffraction | A | ZN, OLY, SO4 | — |
| 6PIY | Crystal structure of HCV NS3/4A D168A protease in complex with P4-2 (NR02-61) | x-ray diffraction | A | OMS, ZN, SO4 | 2 (best 0.39) |
| 6PIY | Crystal structure of HCV NS3/4A D168A protease in complex with P4-2 (NR02-61) | x-ray diffraction | A | OMS, ZN, SO4 | — |
| 6PIZ | Crystal structure of HCV NS3/4A D168A protease in complex with P4-1 (NR02-24) | x-ray diffraction | A | SO4, ON4, ZN | 1 (best 0.32) |
| 6PIZ | Crystal structure of HCV NS3/4A D168A protease in complex with P4-1 (NR02-24) | x-ray diffraction | A | SO4, ON4, ZN | — |
| 6PJ0 | Crystal structure of HCV NS3/4A D168A protease in complex with P4-5 (NR01-97) | x-ray diffraction | A | OMV, ZN, SO4 | — |
| 6PJ0 | Crystal structure of HCV NS3/4A D168A protease in complex with P4-5 (NR01-97) | x-ray diffraction | A | OMV, ZN, SO4 | — |
| 6PJ1 | Crystal structure of HCV NS3/4A D168A protease in complex with P4-4(AJ-74) | x-ray diffraction | A | ZN, GKM, SO4 | 2 (best 0.41) |
| 6PJ1 | Crystal structure of HCV NS3/4A D168A protease in complex with P4- 4(AJ-74) | x-ray diffraction | A | ZN, GKM, SO4 | — |
| 6PJ2 | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-4 (AJ-65) | x-ray diffraction | A | ZN, OM7, SO4 | — |
| 6PJ2 | Crystal structure of HCV NS3/4A D168A protease in complex with P4-P5-4 (aj-65) | x-ray diffraction | A | ZN, OM7, SO4 | — |
| 6VDO | HCV NS3/4A protease A156T, D168E double mutant | x-ray diffraction | A | ZN, SO4 | — |
| 6VDO | HCV NS3/4A protease A156T, D168E double mutant | x-ray diffraction | A | ZN, SO4 | — |
| 7L7N | Crystal structure of HCV NS3/4A D168A protease in complex with NR02-59 | x-ray diffraction | A | ZN, XSV, SO4 | 1 (best 0.31) |
| 7L7N | Crystal structure of HCV NS3/4A D168A protease in complex with NR02-59 | x-ray diffraction | A | ZN, XSV, SO4 | — |
| 7MM2 | Crystal structure of HCV NS3/4A protease in complex with NR02-61 | x-ray diffraction | A | OMS, ZN, SO4 | 3 (best 0.39) |
| 7MM2 | Crystal structure of HCV NS3/4A protease in complex with NR02-61 | x-ray diffraction | A | OMS, ZN, SO4 | — |
| 7MM3 | Crystal structure of HCV NS3/4A protease in complex with NR01-127 | x-ray diffraction | A | ZN, ZJG, SO4 | 1 (best 0.32) |
| 7MM3 | Crystal structure of HCV NS3/4A protease in complex with NR01-127 | x-ray diffraction | A | ZN, ZJG, SO4 | — |
| 7MM4 | Crystal structure of HCV NS3/4A protease in complex with NR01-115 | x-ray diffraction | A | ZN, ZKA, SO4 | 1 (best 0.30) |
| 7MM4 | Crystal structure of HCV NS3/4A protease in complex with NR01-115 | x-ray diffraction | A | ZN, ZKA, SO4 | — |
| 7MM5 | Crystal structure of HCV NS3/4A protease in complex with NR02-60 | x-ray diffraction | A | ZN, ZK4, SO4 | 2 (best 0.39) |
| 7MM5 | Crystal structure of HCV NS3/4A protease in complex with NR02-60 | x-ray diffraction | A | ZN, ZK4, SO4 | — |
| 7MM6 | Crystal structure of HCV NS3/4A protease in complex with NR02-49 | x-ray diffraction | A | ZN, ZJY, SO4 | 1 (best 0.28) |
| 7MM6 | Crystal structure of HCV NS3/4A protease in complex with NR02-49 | x-ray diffraction | A | ZN, ZJY, SO4 | — |
| 7MM7 | Crystal structure of HCV NS3/4A protease in complex with NR02-23 | x-ray diffraction | A | ZJV, ZN, SO4 | 1 (best 0.31) |
| 7MM7 | Crystal structure of HCV NS3/4A protease in complex with NR02-23 | x-ray diffraction | A | ZJV, ZN, SO4 | — |
| 7MM8 | Crystal structure of HCV NS3/4A protease in complex with NR02-08 | x-ray diffraction | A | ZN, ZJM, SO4 | 1 (best 0.31) |
| 7MM8 | Crystal structure of HCV NS3/4A protease in complex with NR02-08 | x-ray diffraction | A | ZN, ZJM, SO4 | — |
| 7MM9 | Crystal structure of HCV NS3/4A protease in complex with NR01-149 | x-ray diffraction | A | ZN, ZJJ, SO4 | 1 (best 0.32) |
| 7MM9 | Crystal structure of HCV NS3/4A protease in complex with NR01-149 | x-ray diffraction | A | ZN, ZJJ, SO4 | — |
12 records more on the page itself.
Ligands
- ZN · Zinc ion · in 72 records
- SO4 · Sulfate ion · in 66 records
- GKA · (2r,6s,12z,13as,14ar,16as)-6-[(N-acetyl-3-methyl-L-valyl)amino]-2-[(7-methoxy-3-methylquinoxalin-2-yl) oxy]-N-[(1-methylcyclopropyl)sulfonyl]-5,16-dioxo-1,2, 3,6,7,8,9,10,11,13A,14,15,16,16A-tetradecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecine-14A(5H)-carboxamide · in 4 records
- GKG · 1,1,1-trifluoro-2-methylpropan-2-yl [(2r,6s,12z,13as, 14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 4 records
- GKM · 1-methylcyclopentyl [(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 4 records
- OMS · 1-methylcyclobutyl [(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 4 records
- ZJG · Cyclobutyl {(2r,4s,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1, 2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl}carbamate · in 4 records
- ZJJ · 3,3-difluorocyclobutyl {(2r,4s,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1, 2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl}carbamate · in 4 records
- ZJM · (1R,2R)-2-fluorocyclopentyl {(2r,4s,6s,12z,13as,14ar, 16AS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl}carbamate · in 4 records
- ZKA · (1-methylcyclopropyl)methyl {(2r,4s,6s,12z,13as,14ar, 16AS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl}carbamate · in 4 records
- ZKJ · (2R)-1,1,1-trifluoropropan-2-yl {(2r,4r,6s,12z,13as, 14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl}carbamate · in 4 records
- FH1 · N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-N-[(1R,2S)-2-ethenyl-1-{[(1-methylcyclopropyl) sulfonyl]carbamoyl}cyclopropyl]-4-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-L-prolinamide · in 2 records
- FH4 · N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-N-[(1R,2S)-2-ethenyl-1-{[(1-methylcyclopropyl) sulfonyl]carbamoyl}cyclopropyl]-4-{[7-methoxy-3-(propan-2-yl)quinoxalin-2-yl]oxy}-L-prolinamide · in 2 records
- FHD · 3-methyl-N-[(pentyloxy)carbonyl]-L-valyl-(4R)-4-[(3-chloro-7-methoxyquinoxalin-2-yl)oxy]-N-[(1R,2S)-2-ethenyl-1-{[(1-methylcyclopropyl) sulfonyl]carbamoyl}cyclopropyl]-L-prolinamide · in 2 records
- GK7 · Methyl [(2S)-1-{[(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]amino}-3,3-dimethyl-1-oxobutan-2-yl]carbamate · in 2 records
- GKJ · Pentyl [(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 2 records
- OL7 · Methyl [(1S)-1-cyclohexyl-2-{[(2r,6s,12z,13as,14ar, 16AS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]amino}-2-oxoethyl]carbamate · in 2 records
- OLJ · (1R,3R,5S)-bicyclo[3.1.0]hexan-3-yl [(2r,6s,12z,13as, 14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 2 records
- OLV · Cyclohexyl [(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5, 16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6- yl]carbamate · in 2 records
- OLY · Methyl (1-{[(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methyl-5,8-dihydroquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamoyl}cyclopentyl) carbamate · in 2 records
- OM7 · (2r,6s,12z,13as,14ar,16as)-6-[(N-acetyl-L-isoleucyl) amino]-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-N-[(1-methylcyclo propyl)sulfonyl]-5,16-dioxo-1,2,3,6,7, 8,9,10,11,13A,14,15,16,16A-tetradecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacycl opentadecine-14A(5H)-carboxamide · in 2 records
- OMV · 1-ethylcyclopentyl [(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 2 records
- ON4 · 1-methylcyclopropyl [(2r,6s,12z,13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2, 3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 2 records
- TSV · (2R,6S,12Z,13aS,14aR,16aS)-6-[(tert-butoxycarbonyl)amino]-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8 ,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoro-2H-isoindole-2-carboxylate · in 2 records
- XSV · 1-(trifluoromethyl)cyclobutyl [(2r,6s,12z,13as,14ar, 16AS)-2-{[6-methoxy-3-(trifluoromethyl)quinoxalin-2-yl]oxy}-14A-{[(1-methylcyclopropyl) sulfonyl]carbamoyl}-5,16-dioxo-1,2,3,5,6,7,8,9,10,11, 13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl]carbamate · in 2 records
- ZJV · (2S)-1,1,1-trifluoropropan-2-yl {(2r,4s,6s,12z,13as, 14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-A][1, 4]diazacyclopentadecin-6-yl}carbamate · in 2 records
- ZJY · [1-(trifluoromethyl)cyclopropyl]methyl {(2R,4S,6S,12Z, 13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl) carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14, 14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl}carbamate · in 2 records
- ZK4 · (1R)-1-cyclopentyl-2,2,2-trifluoroethyl {(2R,4R,6S,12Z, 13as,14ar,16as)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14A-[(1-methylcyclopropane-1-sulfonyl) carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13A,14, 14A,15,16,16A-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl}carbamate · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.